Paolo B. De Ieso

Coburg, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre.

Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre.

Journal: BMC cancer

Published: July 14, 2022

Immunohistochemical investigation of cytokine expression levels as biomarkers in transrectal ultrasound-guided needle biopsy specimens of prostate adenocarcinoma.

Immunohistochemical investigation of cytokine expression levels as biomarkers in transrectal ultrasound-guided needle biopsy specimens of prostate adenocarcinoma.

Journal: Molecular and clinical oncology

Published: October 10, 2020

Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma.

Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: August 25, 2020

Levels of plasma cytokine in patients undergoing neoadjuvant androgen deprivation therapy and external beam radiation therapy for adenocarcinoma of the prostate.

Levels of plasma cytokine in patients undergoing neoadjuvant androgen deprivation therapy and external beam radiation therapy for adenocarcinoma of the prostate.

Journal: Annals of translational medicine

Published: June 23, 2020

The utilization of allied and community health services by cancer patients living in regional and remote geographical areas in Australia.

The utilization of allied and community health services by cancer patients living in regional and remote geographical areas in Australia.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: June 11, 2020

Treatment and outcomes for indigenous and non-indigenous lung cancer patients in the Top End of the Northern Territory.

Treatment and outcomes for indigenous and non-indigenous lung cancer patients in the Top End of the Northern Territory.

Journal: Internal medicine journal

Published: December 29, 2019

Investigation of circulatory cytokines in patients undergoing intensity-modulated radiotherapy (IMRT) for adenocarcinoma of the prostate and association with acute RT-induced toxicity: A prospective clinical study.

Investigation of circulatory cytokines in patients undergoing intensity-modulated radiotherapy (IMRT) for adenocarcinoma of the prostate and association with acute RT-induced toxicity: A prospective clinical study.

Journal: Cytokine

Published: November 18, 2019

Do histopathological features of breast cancer in Australian Indigenous women explain the survival disparity? A two decade long study in the Northern Territory.

Do histopathological features of breast cancer in Australian Indigenous women explain the survival disparity? A two decade long study in the Northern Territory.

Journal: Asia-Pacific journal of clinical oncology

Published: September 09, 2019

Cytokines expression levels from tissue, plasma or serum as promising clinical biomarkers in adenocarcinoma of the prostate: a systematic review of recent findings.

Cytokines expression levels from tissue, plasma or serum as promising clinical biomarkers in adenocarcinoma of the prostate: a systematic review of recent findings.

Journal: Annals of translational medicine

Published: July 19, 2019

Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Journal: Disease markers

Published: June 08, 2018

Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.

Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 13, 2018

Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).

Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).

Journal: The lancet. Gastroenterology & hepatology

Published: August 24, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026